TLPH

5.94% -0.0398

시장 영업 전: .66 0.0298 +4.73%

Talphera Inc (TLPH)

개요 뉴스 가격 이력 토론 예측

Relative Volume:

Talphera Inc Stock (TLPH) Company Profile

Talphera Inc

Healthcare (1176)

650-216-3500

1850 GATEWAY DRIVE, SAN MATEO

최신 SEC 제출 서류

TLPH's Discussions on Twitter

TLPH을(를) 다른 주식과 비교

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
TLPH Talphera Inc	0.6302	10.73M	2.82M	-14.20M	-15.13M	-0.85
ZTS Zoetis Inc	167.53	75.58B	9.15B	2.43B	2.31B	5.32
HLN Haleon Plc Adr	9.24	41.78B	14.26B	1.55B	0	0.3383
TAK Takeda Pharmaceutical Co Adr	13.10	41.53B	30.27B	1.93B	3.45B	0.6044
TEVA Teva Pharmaceutical Industries Ltd Adr	21.82	24.72B	16.77B	-959.00M	1.37B	-0.85
NBIX Neurocrine Biosciences Inc	145.88	14.77B	2.24B	385.90M	440.10M	3.73

Talphera Inc Stock (TLPH) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2020-07-20	다운그레이드	Credit Suisse	Neutral → Underperform
2019-11-11	다운그레이드	Credit Suisse	Outperform → Neutral
2019-08-05	재개	Credit Suisse	Outperform
2019-07-10	재개	Credit Suisse	Outperform
2019-04-24	재개	B. Riley FBR	Buy
2019-02-15	개시	Credit Suisse	Outperform
2018-10-23	개시	B. Riley FBR	Buy
2017-10-13	다운그레이드	Jefferies	Buy → Hold
2017-10-13	재확인	RBC Capital Mkts	Outperform
2017-07-14	재개	Jefferies	Buy
2016-09-15	재확인	ROTH Capital	Buy
2016-08-05	다운그레이드	Stifel	Buy → Hold
2015-10-30	업그레이드	Jefferies	Hold → Buy
2015-10-05	재확인	ROTH Capital	Buy
2015-09-02	개시	H.C. Wainwright	Buy
2015-07-10	재개	ROTH Capital	Buy
2015-05-06	재확인	Mizuho	Neutral
2015-05-05	재확인	RBC Capital Mkts	Outperform
2015-03-10	재확인	RBC Capital Mkts	Outperform
2015-03-09	다운그레이드	Mizuho	Buy → Neutral

Talphera Inc 주식(TLPH)의 최신 뉴스

Talphera Inc (TLPH) 재무 분석

Talphera Inc 주식 (TLPH) 내부자 거래

내부자 거래	관계	날짜	거래	비용	#주식	가치 ($)	#주식 총계
ASADORIAN RAFFI	Chief Financial Officer	Dec 02 '24	Sale	0.77	155	119	37,578
Angotti Vincent J.	CHIEF EXECUTIVE OFFICER	Nov 27 '24	Buy	0.73	5,000	3,650	203,066

Talphera Inc (TLPH)

Talphera Inc Stock (TLPH) Company Profile

TLPH을(를) 다른 주식과 비교

Talphera Inc Stock (TLPH) Upgrades & Downgrades

Talphera Inc 주식(TLPH)의 최신 뉴스

FDA to review Talphera's request to amend NEPHRO study By Investing.com - Investing.com Canada

FDA to review Talphera’s request to amend NEPHRO study By Investing.com - Investing.com Nigeria

FDA to review Talphera's request to amend NEPHRO study - Investing.com

Talphera Announces Agreement with the FDA for Prior Approval Supplement Review to Reduce the Number of Patients in the NEPHRO CRRT Study - Marketscreener.com

TLPH stock touches 52-week low at $0.6 amid market shifts - Investing.com UK

TLPH stock touches 52-week low at $0.61 amid market challenges - Investing.com

Talphera faces Nasdaq delisting over share price rule - Investing.com

Talphera faces Nasdaq delisting over share price rule By Investing.com - Investing.com UK

Acelrx Announces Dsuvia® Milestone C Approval; Provides Revenue Guidance for the First Quarter 2020 - Marketscreener.com

Talphera to Host Third Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday, November 13, 2024 - Kilgore News Herald

Talphera CEO Vincent J. Angotti acquires $3,199 in common stock - Investing.com

Talphera CEO Vincent J. Angotti acquires $3,199 in common stock By Investing.com - Investing.com UK

Talphera CEO Vincent J. Angotti buys $3,649 in company stock By Investing.com - Investing.com Canada

Talphera CFO Raffi Asadorian sells shares worth $118 - Investing.com India

Talphera CEO Vincent J. Angotti buys $3,649 in company stock - Investing.com India

Talphera CFO Raffi Asadorian sells shares worth $118 By Investing.com - Investing.com Canada

Talphera Third Quarter 2024 Earnings: US$0.13 loss per share (vs US$0.085 loss in 3Q 2023) - Yahoo Finance

Talphera (FRA:R5XA) Inventories, Raw Materials & Components : €0.00 Mil (As of Jun. 2024) - GuruFocus.com

Talphera Inc (TLPH) Q3 2024 Earnings Call Highlights: Strategic Advances and Financial Challenges - Yahoo Finance

Talphera: Q3 Earnings Snapshot - mySA

Talphera Reports Q3 2024 Results and Study Progress - TipRanks

Talphera's Q3 Loss Widens to $3.4M as NEPHRO Trial Expands to New Sites | TLPH Stock News - StockTitan

Talphera Announces Third Quarter 2024 Financial Results and Provides Corporate Update - PR Newswire

An Overview of Talphera's Earnings - Benzinga

Talphera Sets Q3 2024 Earnings Call for November 13Key Financial Results Update | TLPH Stock News - StockTitan

Talphera, Inc. (NASDAQ:TLPH) Sees Large Decline in Short Interest - Defense World

Talphera to Participate in Fireside Chat at the 2024 Maxim Healthcare Virtual Summit - Citizentribune

Talphera extends agreement deadline with Nantahala Management By Investing.com - Investing.com Australia

Talphera extends agreement deadline with Nantahala Management - Investing.com

Talphera to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - Kilgore News Herald

Talphera CEO Vincent J. Angotti buys $7.6k in company stock - Investing.com

Credit Suisse gives an Underperform recommendation for Talphera Inc. (TLPH) - Knox Daily

TLPH Stock Earnings: Talphera Beats EPS for Q2 2024 - MSN

Talphera starts key trial for anticoagulant nafamostat - Investing.com India

Talphera starts key trial for anticoagulant nafamostat By Investing.com - Investing.com Canada

Talphera Announces First Patient Enrolled in the Registrational Trial Evaluating Nafamostat for Anticoagulation of the Extracorporeal Circuit - PR Newswire

Talphera First Half 2024 Earnings: US$0.31 loss per share (vs US$0.40 loss in 1H 2023) - Yahoo Finance

Talphera Inc (TLPH) Q2 2024 Earnings Call Transcript Highlights: Strategic Advancements and Financial Adjustments - GuruFocus.com

Talphera: Q2 Earnings Snapshot - San Antonio Express-News

Talphera Announces First Quarter 2024 Financial Results and Provides Corporate Update - Longview News-Journal

Talphera, Inc. (NASDAQ:TLPH) Q2 2024 Earnings Call Transcript - MSN

Talphera Announces CMO Retirement and Successor Appointment - TipRanks

Talphera Inc (TLPH) 재무 분석

매출

순이익

현금흐름

주당 순 이익

Talphera Inc 주식 (TLPH) 내부자 거래

TLPH과 유사한 종목